Drug Recall List
Drug Recall List Drug
Recall Details
Metformin HCl Extended Release CGMP Deviation Tablets
Metformin Hydrochloride Extended-Release 00904579461
Clozapine Tablets 06586284605
CGMP Deviation Presence of foreign tablet
Metformin Hydrochloride Extended-release Tablets 06818033607
Aripiprazole Tablets 06233209730
CGMP Deviations Labeling: Label mix up
Last Updated: July 2020 Contact
Date
If you have questions about this recall, Preferred Pharmaceuticals, Inc, 1714-777-3729. If you have questions about this recall, The Time-Cap, Labs Inc, 1631-753-9090 ext 160 If you have questions about this recall, Aurobindo Pharma USA, Inc, 1-866-850-2876 If you have questions about this recall, Lupin Pharmaceuticals Inc., 1866-587-4617. If you have questions about this recall, Alembic Pharmaceuticals Limited, 1-908-393-9604.
July 2020
July 2020
July 2020
July 2020
July 2020
Drug Recall Class* Class II
Class II
Class II
Class II
Class II
* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.
NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.
Nystatin Cream 00316022130 00316022115
metFORMIN HCL ER 07278900930 07278900960 07278900990 07278900993 49483062301 Metformin Hydrochloride Extended-Release Tablets 04948362301
Subpotent Drug CGMP Deviations CGMP Deviations
If you have questions about this recall, Crown Laboratories, Inc., 1-800877-8869. If you have questions about this recall, Amneal Pharmaceuticals., 1-833582-0812.
July 2020
July 2020
If you have questions about this recall, TimeCap Labs,1-631-753-9090 ext 160
July 2020
Class II Class II Class II
Metformin Hydrochloride
CGMP Deviations
If you have questions
July
Class II
Extended - Release Tablets
about this recall, Teva
2020
06203757101
Pharmaceuticals USA, 1-
06203757110
800-545-8800.
06203757701
06203757710
Metformin Hydrochloride
CGMP Deviations
If you have questions
July
Class II
Extended-Release Tablets
about this recall, Amneal 2020
53746017801
Pharmaceuticals, 1-833-
06516217809
582-0812
06516217850
06516217810
53746017901
06516217910
* Drug Recall Class
Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death.
Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious
adverse health consequences is remote.
Class 3 Recall: Using the drug is not likely to cause adverse health consequences.
NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.
00537460178
53746017805
53746017810
65162017811
00537460179
65162017901
Heparin Sodium
Subpotent Drug
If you have questions
June
Class II
70004065046
about this recall, SCA
2020
Pharmaceuticals, 1-877-
550-5059.
Irinotecan HCL Injection
Defective Container
If you have questions
June
Class II
00143958301
about this recall, West-
2020
Ward Pharmaceutical
Corp, 1-877-845-0689.
Irinotecan HCL Injection
Defective Container
If you have questions
June
Class II
00143970101
about this recall, West-
2020
Ward Pharmaceutical
Corp, 1-877-845-0689.
metFORMIN HCL ER
CGMP Deviations
If you have questions
June
Class II
04306342830
about this recall, Amneal 2020
04306342860
Pharmaceuticals, 1-833-
04306342890
582-0812
04306342898
04306342893
53746017805
Metformin Hydrochloride
CGMP Deviations
If you have questions
June
Class II
Extended-Release Tablets
about this recall, AVKARE 2020
05026853115
Inc., 1-931-292-6222.
04229161090
* Drug Recall Class
Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death.
Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious
adverse health consequences is remote.
Class 3 Recall: Using the drug is not likely to cause adverse health consequences.
NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.
04229161018 04229161036 04229161010
Metformin Hydrochloride Extended-Release Tablets 04229161190 04229161118 04229161150 Metformin Hydrochloride Extended-Release Tablets 06050502601
CGMP Deviations CGMP Deviations
If you have questions
June
about this recall, AVKARE 2020
Inc., 1-931-292-6222.
If you have questions about this recall, Apotex Inc., 1-800-268-4623.
June 2020
Class II Class II
Gaviscon Liquid Antacid Extra Strength, Cool Mint 00135009541
Labeling: Label lacks warning
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry 00135057441
Labeling: Label lacks warning
Gaviscon Regular Strength Liquid Antacid Cool Mint 00135009441
Labeling: Label lacks warning
If you have questions about this recall, Glaxosmithkline Consumer Healthcare Holdings Inc., 1-800-7434014 If you have questions about this recall, Glaxosmithkline Consumer Healthcare Holdings Inc., 1-800-7434014 If you have questions about this recall, Glaxosmithkline Consumer Healthcare
June 2020
June 2020
June 2020
Class II Class II Class II
* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.
NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.
Gaviscon Regular Strength Liquid Antacid Cool Mint 00135009442
Labeling: Label lacks warning
oxyTOCIN 30 Units 070092106807
Lisinopril 06818051303
Unasyn (ampicillin sodium/sulbacatam) 00049001381 00049001383 Doxycycline Hyclate 06258469311
Subpotent drug Product Mix Up Presence of Particulate Matter Failed dissolution specification
Holdings Inc., 1-800-7434014
If you have questions about this recall, Glaxosmithkline Consumer Healthcare Holdings Inc., 1-800-7434014 If you have questions about this recall, QuVa Pharma, Inc., 1-888-3390874. If you have questions about this recall, Lupin Pharmaceuticals Inc., 1866-587-4617. If you have questions about this recall, Pfizer Inc., 1-800-879-3477.
June 2020
June 2020
June 2020
June 2020
If you have questions about this recall, American Health Packaging, 1-614492-8177.
June 2020
Class II
Class II Class II Class II Class II
* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.
NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- science diet recall list 2019
- hills dog food recall list 2019
- blood pressure drug recall 2019
- fda drug recall list 2018
- blood pressure drug recall list
- drug recall list 2018
- drug recall list
- fda drug recall list
- blood pressure drug recall cancer
- fda drug recall list 2019
- fda drug recall losartan 2018
- fda drug recall list 2020